CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG

CAR-T Therapy

CD19/CD22 CAR-T cell therapy

Trial Locations (1)

RECRUITING

Guangzhou Medical University Affiliated Women and Children's Medical Center, Guangzhou

All Listed Sponsors

lead

Guangzhou Women and Children's Medical Center

OTHER